Learn more

IMMUNO BIOLOGICAL LAB CO LTD

Overview
  • Total Patents
    46
  • GoodIP Patent Rank
    236,157
About

IMMUNO BIOLOGICAL LAB CO LTD has a total of 46 patent applications. Its first patent ever was published in 2002. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are MOLECULAR LOGIX INC, SYNTIMMUNE INC and GILEAD BIOLOGICS INC.

Patent filings per year

Chart showing IMMUNO BIOLOGICAL LAB CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Seito Tsutomu 19
#2 Kon Shigeyuki 18
#3 Uede Toshimitsu 13
#4 Yamamoto Nobuchika 9
#5 Maeda Masahiro 9
#6 Suzuki Toshiharu 7
#7 Saeki Yukihiko 5
#8 Noda Masaki 5
#9 Yokosaki Yasuyuki 5
#10 Nakashima Toshihiro 4

Latest patents

Publication Filing date Title
WO2014167826A1 ANTIBODY FOR SPECIFICALLY RECOGNIZING CLEAVAGE SURFACE OF C-TERMINAL FRAGMENT AFTER α-SECRETASE CLEAVAGE OF AMYLOID PRECURSOR PROTEIN AND USE THEREOF
EP2455466A1 Dna fragment and pharmaceutical composition
WO2009075084A1 Agent and method for diagnosis on the occurrence of alzheimer's disease or the tendency to develop alzheimer's disease
CN101563454A Diagnostic agent for mesothelioma, diagnosis kit for mesothelioma, and diagnosis method for mesothelioma
EP2077325A1 Monoclonal antibody and use thereof
WO2005049083A1 Preventive/therapeutic agent for tendon/ligament deterioration
US2007111252A1 Marker peptide for alzheimer's disease
US2007274993A1 Immunocompetent Cell Activation Inhibitor and Use Thereof
EP1434053A1 Reagent for detecting risk factor for alzheimer's disease, detection kit therefor and method of detecting risk factor for alzheimer's disease using the same
WO03027151A1 Recombinant anti-osteopontin antibody and use thereof
EP1754719A2 Anti-osteopontin antibody and use thereof